BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36383383)

  • 1. Safety of Withholding Perioperative Hydrocortisone for Patients With Pituitary Adenomas With an Intact Hypothalamus-Pituitary-Adrenal Axis: A Randomized Clinical Trial.
    Guo X; Zhang D; Pang H; Wang Z; Gao L; Wang Y; Ma W; Lian W; Xing B;
    JAMA Netw Open; 2022 Nov; 5(11):e2242221. PubMed ID: 36383383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of withholding hydrocortisone during preoperative periods in pituitary adenomas patients with an intact HPA axis: A meta-analysis of randomized controlled trials.
    Lin F; Su Y; Zhang X; Liang B; Qin M
    Neuro Endocrinol Lett; 2023 Jun; 44(3):131-139. PubMed ID: 37392440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety.
    Sterl K; Thompson B; Goss CW; Dacey RG; Rich KM; Zipfel GJ; Chicoine MR; Kim AH; Silverstein JM
    Neurosurgery; 2019 Aug; 85(2):E226-E232. PubMed ID: 30325449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose ACTH test for evaluation of hypothalamus-pituitary-adrenal axis preoperatively and 3-month follow-up in non-functioning pituitary adenomas.
    Garg A; Mishra SK; Dubey S; Singh VP; Kuchay MS; Mithal A
    J Endocrinol Invest; 2020 Dec; 43(12):1769-1777. PubMed ID: 32436184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency.
    Gandhi GY
    Ann Intern Med; 2023 Apr; 176(4):JC46. PubMed ID: 37011395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
    Kolnes AJ; Øystese KA; Dahlberg D; Berg-Johnsen J; Niehusmann P; Pahnke J; Bollerslev J; Jørgensen AP
    Acta Neurochir (Wien); 2020 Apr; 162(4):845-852. PubMed ID: 31907611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas.
    Pofi R; Gunatilake S; Macgregor V; Shine B; Joseph R; Grossman AB; Isidori AM; Cudlip S; Jafar-Mohammadi B; Tomlinson JW; Pal A
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5316-5324. PubMed ID: 31225871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?
    Hout WM; Arafah BM; Salazar R; Selman W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1208-12. PubMed ID: 3372683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
    McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
    World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.
    Cozzi R; Lasio G; Cardia A; Felisati G; Montini M; Attanasio R
    J Endocrinol Invest; 2009 May; 32(5):460-4. PubMed ID: 19494715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
    Marko NF; Gonugunta VA; Hamrahian AH; Usmani A; Mayberg MR; Weil RJ
    J Neurosurg; 2009 Sep; 111(3):540-4. PubMed ID: 19326985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective perioperative steroid supplementation protocol in patients undergoing endoscopic transsphenoidal surgery for pituitary adenomas.
    Chacko SR; Abraham AP; Asha HS; Kapoor N; Rajaratnam S; Chacko AG
    Acta Neurochir (Wien); 2020 Oct; 162(10):2381-2388. PubMed ID: 32772164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
    Kristof RA; Wichers M; Haun D; Redel L; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2008 Apr; 150(4):329-35; discussion 335. PubMed ID: 18309452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intraoperative cortisol levels after preoperative hydrocortisone administration versus placebo in patients without adrenal insufficiency undergoing endoscopic transsphenoidal removal of nonfunctioning pituitary adenomas: a double-blind randomized trial.
    Lee HC; Yoon HK; Kim JH; Kim YH; Park HP
    J Neurosurg; 2020 Jan; 134(2):526-534. PubMed ID: 31978882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MORNING SERUM CORTISOL LEVEL AFTER TRANSSPHENOIDAL SURGERY FOR PITUITARY ADENOMA PREDICTS HYPOTHALAMIC-PITUITARY-ADRENAL FUNCTION DESPITE INTRAOPERATIVE DEXAMETHASONE USE.
    Manuylova E; Calvi LM; Vates GE; Hastings C; Shafiq I
    Endocr Pract; 2015 Aug; 21(8):897-902. PubMed ID: 26121454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.
    Marko NF; Hamrahian AH; Weil RJ
    Pituitary; 2010 Sep; 13(3):249-55. PubMed ID: 20339931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Basal Cortisol Level as a Predictor of Hypothalamic-Pituitary-Adrenal (HPA) Axis Function After Pituitary Tumor Surgery.
    Polovina TS; Kraljevic I; Solak M; Balasko A; Haxhiu A; Haxhiu A; Dusek T; Poljicanin T; Kastelan D
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):709-714. PubMed ID: 31091548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative management of the hypothalamic-pituitary-adrenal axis in patients with pituitary adenomas: an Australasian survey.
    Joseph SP; Ho JT; Doogue MP; Burt MG
    Intern Med J; 2012 Oct; 42(10):1120-4. PubMed ID: 21883779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UTILITY OF A GLUCOCORTICOID SPARING STRATEGY IN THE MANAGEMENT OF PATIENTS FOLLOWING TRANSSPHENOIDAL SURGERY.
    Jia X; Pendharkar AV; Loftus P; Dodd RL; Chu O; Fraenkel M; Katznelson L
    Endocr Pract; 2016 Sep; 22(9):1033-9. PubMed ID: 27124693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
    Jayasena CN; Gadhvi KA; Gohel B; Martin NM; Mendoza N; Meeran K; Dhillo WS
    Clin Chem; 2009 May; 55(5):972-7. PubMed ID: 19282356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.